e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
130.34
+0.06 (+0.05%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 22, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
4,757,766
Open
131.83
Bid (Size)
130.34 (200)
Ask (Size)
131.00 (200)
Prev. Close
130.28
Today's Range
130.23 - 132.86
52wk Range
108.06 - 157.29
Shares Outstanding
1,253,809,440
Dividend Yield
2.52%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Is the iShares Healthcare ETF or the Invesco Nasdaq Biotech ETF the Better Bet for Investors in 2026?
↗
Today 16:01 EDT
One offers global diversification and higher income; the other delivers focused biotech exposure with lower costs and stronger recent gains.
Via
The Motley Fool
Topics
ETFs
Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026
July 21, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Performance
YTD
+7.2%
+7.2%
1 Month
+4.4%
+4.4%
3 Month
-1.9%
-1.9%
6 Month
+0.9%
+0.9%
1 Year
+18.3%
+18.3%
More News
Read More
Gilead, Merck Advance Potential Blockbuster Weekly HIV Pill
↗
July 21, 2026
Via
Benzinga
Investigational Once-Weekly Oral HIV Treatment Regimen of Islatravir and Lenacapavir Maintained Virological Suppression in Adults With HIV Who Switched Antiretroviral Therapy
July 21, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
Gilead to Present New HIV Research at AIDS 2026 Across Prevention, Treatment and Cure
July 21, 2026
From
Gilead Sciences, Inc.
Via
Business Wire
3 Market-Beating Stocks with Solid Fundamentals
July 21, 2026
Via
StockStory
Topics
Energy
Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
↗
July 20, 2026
Via
Benzinga
IHE vs. BBH: Which Healthcare ETF Is the Better Buy Right Now?
↗
July 19, 2026
Via
The Motley Fool
Topics
ETFs
IXJ vs. IBBQ: Global Healthcare vs. Biotech -- Which ETF Is the Better Buy?
↗
July 18, 2026
Via
The Motley Fool
Topics
ETFs
Gilead Leads The Battle Vs. HIV. But Rivals Are On The Move.
↗
July 17, 2026
Via
Investor's Business Daily
Topics
Intellectual Property
Kalshi Will Let Traders Bet on FDA Drug Approvals Despite Critics' Insider Trading Warnings
↗
July 16, 2026
Via
Benzinga
Invesco Healthcare ETF vs VanEck Biotech: Which ETF Will Deliver the Healthiest Returns for 2026?
↗
July 14, 2026
Via
The Motley Fool
Topics
ETFs
Spotting Winners: Gilead Sciences (NASDAQ:GILD) And Therapeutics Stocks In Q1
July 13, 2026
Via
StockStory
Topics
Artificial Intelligence
Many Investors Are Still Treating Gilead Sciences Like a Has-Been HIV Stock. 4 Drug Launches This Year Could Prove Them Wrong.
↗
July 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Which is Best for Investors: Healthcare Stability (XLV) or Biotech Growth (IBBQ)?
↗
July 11, 2026
Via
The Motley Fool
Topics
ETFs
Which is the Better Choice for Healthcare Investors? IYH or BBH?
↗
July 11, 2026
Via
The Motley Fool
Topics
ETFs
What's going on in today's session: S&P500 movers
↗
July 10, 2026
Via
Chartmill
2 Recession-Resistant Dividend Stocks to Buy and Hold
↗
July 10, 2026
Via
The Motley Fool
Topics
Economy
IHE vs. IBB: Which iShares Healthcare ETF Is the Better Buy?
↗
July 10, 2026
Via
The Motley Fool
Topics
ETFs
Which Healthcare ETF Is the Better Buy: Invesco's IBBQ or State Street's XPH?
↗
July 08, 2026
Via
The Motley Fool
Topics
ETFs
BBH vs. XPH: Which Healthcare ETF Is Better for Beginners?
↗
July 08, 2026
Via
The Motley Fool
Topics
ETFs
Stay informed with the top movers within the S&P500 index on Tuesday.
↗
July 07, 2026
Via
Chartmill
Generic Fears Overdone? Gilead Stock Has More Room to Run, Analyst Says
↗
July 06, 2026
Via
Benzinga
MissionIRNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5 Billion ADC Acquisition
July 06, 2026
Via
Investor Brand Network
FHLC vs. BBH: Which Healthcare ETF Is the Better Buy?
↗
July 04, 2026
Via
The Motley Fool
Topics
ETFs
Frequently Asked Questions
Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 130.34
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 07/22/26 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 163.42B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 163B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
wpDiscuz
Insert